Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Rowland

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Brain Research|December 1, 2009
Intermittent high-dose ethanol exposures increase motivation for operant ethanol self-administration: possible neurochemical mechanismZhimin Li, Alevtina Zharikova, Cheryl H Vaughan, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 25, 2014
A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychosesClinton E Canal, Drake Morgan, Daniel Felsing, et al.
Brain Research|November 23, 2006
PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pah(enu2) miceJennifer E Embury, Catherine E Charron, Anatoly Martynyuk, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Brain Research|December 1, 2009
Intermittent high-dose ethanol exposures increase motivation for operant ethanol self-administration: possible neurochemical mechanismZhimin Li, Alevtina Zharikova, Cheryl H Vaughan, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 25, 2014
A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychosesClinton E Canal, Drake Morgan, Daniel Felsing, et al.
Brain Research|November 23, 2006
PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pah(enu2) miceJennifer E Embury, Catherine E Charron, Anatoly Martynyuk, et al.
Pageof 7